Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 18
1979 22
1980 10
1981 9
1982 8
1983 10
1984 17
1985 12
1986 16
1987 11
1988 10
1989 10
1990 13
1991 6
1992 8
1993 4
1994 10
1995 9
1996 13
1997 14
1998 13
1999 22
2000 26
2001 24
2002 17
2003 26
2004 32
2005 21
2006 23
2007 15
2008 20
2009 9
2010 14
2011 18
2012 12
2013 10
2014 3
2015 4
2016 4
2017 6
2018 1
2019 2
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

539 results
Results by year
Filters applied: . Clear all
Page 1
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.
Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN. Symmans WF, et al. Among authors: buzdar au. J Clin Oncol. 2017 Apr 1;35(10):1049-1060. doi: 10.1200/JCO.2015.63.1010. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135148 Free PMC article.
Anastrozole.
Kelly CM, Buzdar AU. Kelly CM, et al. Among authors: buzdar au. Expert Opin Drug Saf. 2010 Nov;9(6):995-1003. doi: 10.1517/14740338.2010.515977. Expert Opin Drug Saf. 2010. PMID: 20923259 Review.
Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.
Mittendorf EA, Jeruss JS, Tucker SL, Kolli A, Newman LA, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Mittendorf EA, et al. Among authors: buzdar au. J Clin Oncol. 2011 May 20;29(15):1956-62. doi: 10.1200/JCO.2010.31.8469. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21482989 Free PMC article.
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, et al. Among authors: buzdar a. Lancet Oncol. 2008 Jan;9(1):45-53. doi: 10.1016/S1470-2045(07)70385-6. Lancet Oncol. 2008. PMID: 18083636 Clinical Trial.
TAS-108: a novel steroidal antiestrogen.
Buzdar AU. Buzdar AU. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):906s-8s. Clin Cancer Res. 2005. PMID: 15701885 Free article. Review.
Are aromatase inhibitors superior to antiestrogens?
Howell A, Buzdar A. Howell A, et al. Among authors: buzdar a. J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):237-47. doi: 10.1016/j.jsbmb.2005.02.004. J Steroid Biochem Mol Biol. 2005. PMID: 15860266 Review.
Evolving novel anti-HER2 strategies.
Jones KL, Buzdar AU. Jones KL, et al. Among authors: buzdar au. Lancet Oncol. 2009 Dec;10(12):1179-87. doi: 10.1016/S1470-2045(09)70315-8. Lancet Oncol. 2009. PMID: 19959074 Review.
539 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page